Team publications 2020

1. HANDALA L, BLANCHARD E, RAYNAL, PI, ROINGEARD P, MOREL V, DESCAMPS V, CASTELAIN S, FRANÇOIS C, DUVERLIE G, BROCHOT E, HELLE F. BK polyomavirus hijacks extracellular vesicles for en bloc transmission. J Virol 2020 ; 94: e01834-19

2. ROINGEARD P, BEAUMONT E. Hepatitis C vaccine : 10 good reasons for continuing. Hepatology 2020 ; 71: 1845-1850.

3. PILLONEL J, PELAT C, TIBERGHIEN P, SAUVAGE C, DANIC B, MARTINAUD C, BARIN F, SAINTE-MARIE I, COIGNARD B, GROSS S, LAPERCHE S, LOT F. The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France. Transfusion 2020 ; 60:525-534.

4. BASSET J, BURLAUD-GAILLARD J, FEHER M, ROINGEARD P, REY F, PARDIGON N. A molecular determinant of West Nile virus secretion and 1 morphology as a target for viral attenuation. J Virol 2020 ; 94: e00086-20.

5. HERRSCHER C, PASTOR F, BURLAUD-GAILLARD J, DUMANS A, SEIGNEURET F, MOREAU A, EYMIEUX S, HOURIOUX C, ROINGEARD P, BLANCHARD E. Hepatitis B virus entry into HepG2-NTCP cells depends on clathrin-mediated endocytosis. Cell Microbiol 2020, e13205.

6. RAT V, PINSON X, SEIGNEURET F, DURAND S, HERRSCHER C, LEMOINE R, BURLAUD-GAILLARD J, RAYNAL PI, HOURIOUX C, ROINGEARD P, TRAMIER M, DE ROCQUIGNY H. Hepatitis B virus core protein domains essential for viral capsid assembly in a cellular context. J Mol Biol 2020, in press

7. HERRSCHER C, ROINGEARD P, BLANCHARD E. Hepatitis B virus entry into cells. Cells 2020 ; 9: e1486.

8. STEFIC K, MAHJOUB N, DESOUCHE C, NÉRÉ ML, THIERRY D, DELAUGERRE C, BARIN F, CHAIX ML. Difficulties of Identifying the Early HIV Antibody Seroconversion Period Depending on the Confirmatory Assay. Open Forum Infect Dis 2020 ; 7:ofaa140.

9. TROUILLER P, VELTER A, SABONI L, SOMMEN C, SAUVAGE C, VAUX S, BARIN F, CHEVALIEZ S, LOT F, JAUFFRET-ROUSTIDE M and the Prevagay group. Injecting drug use during sex (known as "slamming") among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France. Int J Drug Policy 2020 ; 79:102703.

10. CHAZAL N, DE ROCQUIGNY H, ROUSSEL P, BOUAZIZ S, BARRE-SINOUSSI F, DELFRAISSY JF, DARLIX JL. The three lives of Pierre Boulanger. Retrovirology 2020 ; 17: 9.

11. BOSSEBOEUF A, MENNESSON N, ALLAIN-MAILLET S, TALLET A, PIVER E, DECAUX O, MOREAU C, MOREAU P, LEHOURS P, MÉGRAUD F, SALLE V, BIGOT-CORBEL E, HARB J, HERMOUET S. Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1. Cancers 2020 ;12:1254.

12. AIDOUD A, MARLET J, ANGOULVANT D, DEBACQ C, GAVAZZI G, FOUGÈRE B. Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults. Vaccine 2020 ; 38:4944-4955.

13. GONZALES B, DE ROCQUIGNY H, BEZIAU A, DURAND S, BURLAUD-GAILLARD J, LEFEBVRE, KRULL S, EMOND P, BRAND D, PIVER E. Type I phosphatidylinositol-4-phosphate 5-kinase alpha and gamma play a key role in targeting HIV-1 PR55Gag to the plasma membrane. J Virol 2020, in press

14. BEAUMONT E, CLÉMENT BJ, GUÉRIN V, CHOPIN L, ROCH E, GOMEZ-ESCOBAR E, ROINGEARD P. Mixing particles from various HCV genotypes increases the HBV-HCV vaccine ability to elicit broadly cross-neutralizing antibodies. Liver International 2020, in press

15. DE ROCQUIGNY H, RAT V, PASTOR F, DARLIX JL, HOURIOUX C, ROINGEARD P. Phosphorylation of the arginine rich C-terminal domain of the hepatitis B virus (HBV) core protein as a fine regulator of the HBV life cycle. Viruses 2020 ; in press

16. LEGROS V, JEANNIN P, BURLAUD-GAILLARD J, CHAZE T, GIAIA GIANETTO Q, BUTLER-BROWNE G, MOULY V, ZOLADEK J, AFONSO P, GONZALEZ M-N, MATONDO M, RIEDETER I, ROINGEARD P, GESSAIN A, CHOUMET V, CECCALDI P-E. Differentiation-dependent susceptibility of human muscle cells to Zika virus infection. PloS Negl Trop Dis 2020, in press

17. AMBLARD F, BOUCLE S, BASSIT L, COX B, SARI O, TAO S, CHEN Z, OZTURK T, VERMA K, RUSSELL O, RAT V, DE ROCQUIGNY H, FIQUET O, BOUSSAND M, DI SANTO J, STRICK-MARCHAND H, SCHINAZI RF. Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses in Vitro and in Humanized Mice. Antimicrob Agents Chemother 2020 ; pii e01701-19.

18. BAILLY E, STEFIC K, GATAULT P, MIQUELESTORENA-STANDLEY E, MACHET MC, BARBET C, BARIN F, HALIMI JM. Prevention of parvovirus B19-induced repetitive acute kidney failure by subcutaneous immunoglobulins. Fundam Clin Pharmacol 2020 ; 34: 296-298